Xynomic pharmaceuticals holdings, inc. (XYN)
CashFlow / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income

-

-

140

-

-

-

75

66

-75

-31

-0

-1

Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account

-

-

347

-

-

-

220

168

166

6

0

0

Unrealized loss on marketable securities held in Trust Account

-

-

-2

-

-

-

-19

-21

21

-17

0

0

Changes in operating assets and liabilities:
Prepaid expenses

59

-107

-12

-450

39

371

-22

-18

83

24

0

0

Accounts payable and accrued expenses

-

-

62

-

-

-

36

24

23

30

0

0

Net cash used in operating activities

-1,184

-7,852

-129

5,977

-3,657

-2,940

-67

-38

-323

-14

-0

-1

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash withdrawn from Trust Account

0

8,132

55,177

-

-

-

-

-

-

-

-

-

Investment of cash and securities held in Trust Account

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in)/provided by investing activities

18

8,080

55,177

-

-

-

-

-

-

-

-

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of advances from related parties

-

-

-

-

-

-

0

0

0

70

87

0

Proceeds from issuance of ordinary shares

-

-

-

-

-

-

0

0

0

0

25

0

Proceeds from sale of Units, net of underwriting discounts paid

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of Private Units

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of unit purchase option

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from promissory note - related party

-

-

-

-

-

-

0

0

0

70

1

0

Proceeds from promissory note - related party

-

-

10

-

-

-

-

-

-

-

-

300

Redemption of ordinary shares

-

-

55,177

-

-

-

-

-

-

-

-

-

Repayment of promissory note - related party

-

-

-

-

-

-

-

-

-

-

-

0

Payment of offering costs

-

-

-

-

-

-

0

-

-

-

176

0

Net cash provided by/(used in) financing activities

38

-3,692

-55,167

-18,167

13,430

5,336

0

0

0

62,409

-237

300

NET INCREASE/(DECREASE) IN CASH

-1,164

-3,435

-119

-12,096

11,320

755

-67

-38

-323

510

-237

298

NON-CASH INVESTMENT AND FINANCING ACTIVITIES
Change in value of ordinary shares subject to possible redemption

-

-

-140

-

-

-

-34

-

75

31

0

0

Conversion of promissory notes to convertible promissory notes

-

-

100

-

-

-

-

-

-

-

-

-

Accrued offering costs

-

-

-

-

-

-

0

-

-

-

31

142

Offering costs charged to additional paid in capital

-

-

-

-

-

-

-

-

-

-

-

0

Initial classification of ordinary shares subject to possible redemption

-

-

-

-

-

-

-

-

-

-

-

0

Payment of offering costs through advances from related party

-

-

-

-

-

-

-

-

-

-

-

87

Subscription receivable

-

-

-

-

-

-

-

-

-

-

-

25